- Home
- / LexaGene
LexaGene
Stock Price
$0.1
2023-04-25
Market Capitalization
$11.3 M
2023-04-25
LexaGene Summary
Company Summary
- Overview
- LexaGene is a biotechnology company a genetic analyzing platform for pathogen detection. It is used in human and veterinary diagnostics, water quality monitoring, food safety, and more.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- Beverly, MA, US | view all locations
- Website
- https://lexagene.com/
- Cybersecurity rating
Table of Contents
Key People
Steve Armstrong, Chief Operating Officer
Jeffrey Mitchell, Chief Financial Officer
Nathan Walsh, Vice President of Applications, Bioinformatics
LocationsView all
1 location detected
Beverly, MA HQ
United States
500 Cummings Center Suite 4550
LexaGene Financials
Summary Financials
- Revenue (Q3, 2023)
- $42.9K
- Gross profit (Q3, 2023)
- ($147.0K)
- Net income (Q3, 2023)
- ($1.7M)
- Cash (Q3, 2023)
- $464.1K
- EBIT (Q3, 2023)
- ($1.7M)
- Enterprise value
- $12.6M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026